Zhejiang Taimei Medical Technology Co., Ltd. (HKG:2576)
Hong Kong
· Delayed Price · Currency is HKD 4.500
+0.080 (1.81%)
Apr 29, 2026, 3:57 PM HKT
HKG:2576 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2018 |
| Revenue | 512.54 | 551.16 | 573.14 | 549.22 | 466.18 | Upgrade
|
| Revenue Growth (YoY) | -7.01% | -3.84% | 4.36% | 17.81% | 53.88% | Upgrade
|
| Cost of Revenue | 295 | 326.21 | 394.14 | 363.81 | 301.85 | Upgrade
|
| Gross Profit | 217.54 | 224.94 | 179 | 185.4 | 164.33 | Upgrade
|
| Selling, General & Admin | 202.01 | 408.99 | 419.12 | 473.79 | 446.23 | Upgrade
|
| Research & Development | 78.67 | 87.05 | 169.19 | 208.18 | 190.84 | Upgrade
|
| Other Operating Expenses | -7.22 | -9.64 | -16.24 | -15.69 | -13.56 | Upgrade
|
| Operating Expenses | 273.45 | 489.99 | 580.4 | 670.84 | 626.92 | Upgrade
|
| Operating Income | -55.91 | -265.05 | -401.4 | -485.44 | -462.59 | Upgrade
|
| Interest Expense | -0.83 | -0.73 | -1.43 | -2.68 | -2.71 | Upgrade
|
| Interest & Investment Income | 35.65 | 37.05 | 41.65 | 22.88 | 28.74 | Upgrade
|
| Currency Exchange Gain (Loss) | -29.6 | 17.48 | 8.65 | 54.03 | -7.96 | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | - | 1.27 | -0.82 | Upgrade
|
| EBT Excluding Unusual Items | -50.7 | -211.25 | -352.53 | -409.94 | -445.33 | Upgrade
|
| Impairment of Goodwill | - | -9.8 | -8.37 | -22.38 | -54.09 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | 3.76 | 5.84 | 9.79 | 19.8 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | -0.17 | - | -0.47 | 0.02 | Upgrade
|
| Asset Writedown | - | - | -1.2 | - | - | Upgrade
|
| Other Unusual Items | - | 0.04 | -0.11 | 0.42 | - | Upgrade
|
| Pretax Income | -50.7 | -217.41 | -356.36 | -422.58 | -479.61 | Upgrade
|
| Income Tax Expense | - | - | 0.02 | - | 0.01 | Upgrade
|
| Earnings From Continuing Operations | -50.7 | -217.41 | -356.38 | -422.58 | -479.61 | Upgrade
|
| Minority Interest in Earnings | 7.86 | 2.8 | 9.6 | 9.67 | - | Upgrade
|
| Net Income | -42.85 | -214.61 | -346.78 | -412.91 | -479.61 | Upgrade
|
| Net Income to Common | -42.85 | -214.61 | -346.78 | -412.91 | -479.61 | Upgrade
|
| Shares Outstanding (Basic) | 564 | 544 | 538 | 538 | 538 | Upgrade
|
| Shares Outstanding (Diluted) | 564 | 544 | 538 | 538 | 538 | Upgrade
|
| Shares Change (YoY) | 3.65% | 1.10% | - | - | 15.22% | Upgrade
|
| EPS (Basic) | -0.08 | -0.39 | -0.64 | -0.77 | -0.89 | Upgrade
|
| EPS (Diluted) | -0.08 | -0.39 | -0.64 | -0.77 | -0.89 | Upgrade
|
| Free Cash Flow | - | -207.3 | -355.52 | -353.62 | -247.63 | Upgrade
|
| Free Cash Flow Per Share | - | -0.38 | -0.66 | -0.66 | -0.46 | Upgrade
|
| Gross Margin | 42.44% | 40.81% | 31.23% | 33.76% | 35.25% | Upgrade
|
| Operating Margin | -10.91% | -48.09% | -70.04% | -88.39% | -99.23% | Upgrade
|
| Profit Margin | -8.36% | -38.94% | -60.50% | -75.18% | -102.88% | Upgrade
|
| Free Cash Flow Margin | - | -37.61% | -62.03% | -64.39% | -53.12% | Upgrade
|
| EBITDA | -39.53 | -248.66 | -378.66 | -463.41 | -451.58 | Upgrade
|
| EBITDA Margin | -7.71% | -45.12% | -66.07% | -84.38% | -96.87% | Upgrade
|
| D&A For EBITDA | 16.39 | 16.39 | 22.74 | 22.03 | 11 | Upgrade
|
| EBIT | -55.91 | -265.05 | -401.4 | -485.44 | -462.59 | Upgrade
|
| EBIT Margin | -10.91% | -48.09% | -70.04% | -88.39% | -99.23% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.